These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19177568)

  • 1. Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue.
    Yilmaz Y; Ozdogan O
    Hepatology; 2009 Feb; 49(2):698; author reply 698. PubMed ID: 19177568
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and Mediterranean diet?
    Panza F; Capurso C; Solfrizzi V
    Am J Cardiol; 2006 Oct; 98(8):1120-1. PubMed ID: 17027584
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
    Xu G; Zhou Z; Zhu W; Fan X; Liu X
    J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Cancer as a risk factor for dementia: a house built on shifting sand.
    Heflin LH; Meyerowitz BE; Hall P; Lichtenstein P; Johansson B; Pedersen NL; Gatz M
    J Natl Cancer Inst; 2005 Oct; 97(20):1550-1; author reply 1551-2. PubMed ID: 16234571
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression as a risk factor for later dementia: a robust relationship?
    Mitchell AJ
    Age Ageing; 2005 May; 34(3):207-9. PubMed ID: 15863404
    [No Abstract]   [Full Text] [Related]  

  • 6. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET.
    Peters R; Beckett N; Geneva M; Tzekova M; Lu FH; Poulter R; Gainsborough N; Williams B; de Vernejoul MC; Fletcher A; Bulpitt C
    Age Ageing; 2009 Sep; 38(5):521-7. PubMed ID: 19553357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usage of drugs with potential adverse effects on cognition in a memory-clinic].
    Weih M; Scholz S; Reiss K; Alexopoulos P; Degirmenci U; Richter-Schmidinger T; Kornhuber J
    Fortschr Neurol Psychiatr; 2009 Sep; 77(9):523-7. PubMed ID: 19644785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?
    Grau-Olivares M; Arboix A
    Expert Rev Neurother; 2009 Aug; 9(8):1201-17. PubMed ID: 19673608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can heart diseases a known effect on cognitive function?].
    Staszewski J
    Kardiol Pol; 2009 May; 67(5):494-5. PubMed ID: 19610250
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
    Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; van der Flier WM; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
    Cerebrovasc Dis; 2009; 27(4):384-91. PubMed ID: 19276621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible predictors of vascular cognitive impairment-no dementia.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Seripa D; Pilotto A; Vendemiale G; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2009 May; 57(5):943-4. PubMed ID: 19470030
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey.
    Arslantaş D; Ozbabalik D; Metintaş S; Ozkan S; Kalyoncu C; Ozdemir G; Arslantas A
    J Clin Neurosci; 2009 Nov; 16(11):1455-9. PubMed ID: 19748273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive failure in terminal kidney disease].
    Saele K; Sønnesyn H; Svarstad E; Aarsland D
    Tidsskr Nor Laegeforen; 2009 Feb; 129(4):296-9. PubMed ID: 19219095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine-induced mental confusion in patients with cirrhosis.
    Schentag JJ
    Gastroenterology; 1980 Oct; 79(4):780-1. PubMed ID: 7409403
    [No Abstract]   [Full Text] [Related]  

  • 20. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.